Evidence map›Paper›PMID 32832891›Full record

ArticleMedicine and pharmacy reports2020

Quercetin and curcumin effects in experimental pleural inflammation.

Cristina Bidian, Daniela-Rodica Mitrea, Olivia Gabriela Vasile, Adriana Filip, Adriana Florinela Cătoi, Remus Moldovan, Nicoleta Decea, Adriana Albu

Open access · diamondAbstract read
In one paragraph

Article in Medicine and pharmacy reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Synthetic Pathways and the Therapeutic Potential of Quercetin and Curcumin.International journal of molecular sciences · 2022
    Review
  9. Polyphenols as Potent Epigenetics Agents for Cancer.International journal of molecular sciences · 2022
    Review
  10. Therapeutic effect of oral quercetin in hamsters infected withFrontiers in cellular and infection microbiology · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cristina BidianPhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Daniela-Rodica MitreaPhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Olivia Gabriela VasilePhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Adriana FilipPhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Adriana Florinela CătoiPathophysiology Department. Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Remus MoldovanPhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Nicoleta DeceaPhysiology Department, Functional Biosciences Division, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Adriana AlbuInternal Medicine Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe inflammatory mechanisms occur with the highest prevalence in pulmonary pathology in addition to oxidative stress and activation of intracellular signaling pathways. The oxidative stress represents the imbalance between pro-oxidants and antioxidants which can lead to the activation of the oxidative mechanisms with noxious potential to the body. Therefore, finding a therapy that would counteract the injurious effects of free radicals and inflammation is highly attractive. Quercetin is the most active flavonoid, with important anti-inflammatory and antioxidant effects, while curcumin has antioxidant effects that are similar to the standard antioxidants and exerts direct anti-inflammatory activity.

aimsThe aim of this study is to evaluate the antioxidant effects of quercetin and curcumin on an experimental model, pleural inflammation induced by carrageenan.

methodsEight groups of adult male rats were used: Ia and Ib - control groups, IIa and IIb - with carrageenan administration, IIIa and IIIb - received curcumin and carrageenan, IVa and IVb - quercetin and carrageenan administration. Blood and lung samples were taken at 4 hours (Ia, IIa, IIIa, IVa groups) and at 24 hours (Ib, IIb, IIIb, IVb groups) after carrageenan injection.

resultsAt 4 and at 24 hours, curcumin and quercetin have shown protective systemic effects, decreasing significantly the oxidative stress (malondialdehyde level) and stimulating significantly the antioxidant protection (ceruloplasmin and glutathione levels) compared to the group that received only carrageenan. In the lungs, at 4 hours, the redox misbalance was significantly reduced only in animals that were treated with quercetin, modifications that were not observed at 24 hours.

conclusionsIn serum, curcumin presented higher antioxidant effects, compared to quercetin. In lungs, quercetin administration showed superior beneficial effects, but only temporarily.

Indexed as

carrageenancurcuminoxidative stresspleural inflammationquercetin

Identifiers

PMID32832891
PMCPMC7418839
OpenAlexW3009300816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.